COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 21 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130,278 | -30.7% | 23,140 | -0.1% | 0.00% | 0.0% |
| Q2 2023 | $187,917 | +15.8% | 23,171 | +0.2% | 0.00% | 0.0% |
| Q1 2023 | $162,302 | -16.2% | 23,120 | -0.3% | 0.00% | 0.0% |
| Q4 2022 | $193,637 | +21.8% | 23,190 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $159,000 | -15.9% | 23,190 | -0.1% | 0.00% | 0.0% |
| Q2 2022 | $189,000 | -53.1% | 23,210 | -5.7% | 0.00% | -50.0% |
| Q4 2021 | $403,000 | – | 24,623 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 563,030 | $9,504,000 | 12.59% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 570,901 | $9,648,000 | 1.85% |
| VILLERE ST DENIS J & CO LLC | 248,150 | $4,193,000 | 0.24% |
| Weil Company, Inc. | 24,558 | $415,000 | 0.22% |
| ACT CAPITAL MANAGEMENT, LLC | 7,500 | $127,000 | 0.07% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 57,644 | $973,000 | 0.05% |
| FNY Investment Advisers, LLC | 4,000 | $67,000 | 0.03% |
| Sigma Planning Corp | 18,635 | $315,000 | 0.01% |
| ARK Investment Management | 191,290 | $3,233,000 | 0.01% |
| BROWN ADVISORY INC | 61,450 | $1,039,000 | 0.00% |